Faculty profile
Marc Shulman
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
The concerted action of Msh2 and UNG stimulates somatic hypermutation at A . T base pairs.
Molecular and cellular biology · 2009
Latest funding
- $100,000
Immunoglobulin engineering: an improved technology based on homologous recombination
NSERC · 1989 · Principal investigator
1 publications.
The concerted action of Msh2 and UNG stimulates somatic hypermutation at A . T base pairs.
Frieder D, Larijani M, Collins C, Shulman M, Martin A
Immunoglobulin engineering: an improved technology based on homologous recombination
Principal investigators: Shulman, Marc
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.